Genpharmasec Ltd (NSE: GENPHARMA), ISIN INE861N01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GENPHARMA last traded at ₹1.03 (+0.98%), with a 52-week range of ₹0.75 to ₹2.20 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 29.98%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.